151 related articles for article (PubMed ID: 25308845)
1. Changes in subcellular localization of visfatin in human colorectal HCT-116 carcinoma cell line after cytochalasin B treatment.
Bułdak RJ; Skonieczna M; Bułdak Ł; Matysiak N; Mielańczyk Ł; Wyrobiec G; Kukla M; Michalski M; Żwirska-Korczala K
Eur J Histochem; 2014 Sep; 58(3):2408. PubMed ID: 25308845
[TBL] [Abstract][Full Text] [Related]
2. Viability and oxidative response of human colorectal HCT-116 cancer cells treated with visfatin/eNampt in vitro.
Buldak RJ; Gowarzewski M; Buldak L; Skonieczna M; Kukla M; Polaniak R; Zwirska-Korczala K
J Physiol Pharmacol; 2015 Aug; 66(4):557-66. PubMed ID: 26348080
[TBL] [Abstract][Full Text] [Related]
3. Visfatin mediates doxorubicin resistance in human colorectal cancer cells via up regulation of multidrug resistance 1 (MDR1).
Yan X; Zhao J; Zhang R
Cancer Chemother Pharmacol; 2017 Aug; 80(2):395-403. PubMed ID: 28667355
[TBL] [Abstract][Full Text] [Related]
4. Visfatin is involved in promotion of colorectal carcinoma malignancy through an inducing EMT mechanism.
Yang J; Zhang K; Song H; Wu M; Li J; Yong Z; Jiang S; Kuang X; Zhang T
Oncotarget; 2016 May; 7(22):32306-17. PubMed ID: 27058759
[TBL] [Abstract][Full Text] [Related]
5. Induction of growth cessation by acacetin via β-catenin pathway and apoptosis by apoptosis inducing factor activation in colorectal carcinoma cells.
Prasad N; Sharma JR; Yadav UCS
Mol Biol Rep; 2020 Feb; 47(2):987-1001. PubMed ID: 31734898
[TBL] [Abstract][Full Text] [Related]
6. Role of visfatin in promoting proliferation and invasion of colorectal cancer cells by downregulating SDF-1/CXCR4-mediated miR-140-3p expression.
Zhao Q; Li JY; Zhang J; Long YX; Li YJ; Guo XD; Wei MN; Liu WJ
Eur Rev Med Pharmacol Sci; 2020 May; 24(10):5367-5377. PubMed ID: 32495871
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-34a and MicroRNA-181a Mediate Visfatin-Induced Apoptosis and Oxidative Stress via NF-κB Pathway in Human Osteoarthritic Chondrocytes.
Cheleschi S; Tenti S; Mondanelli N; Corallo C; Barbarino M; Giannotti S; Gallo I; Giordano A; Fioravanti A
Cells; 2019 Aug; 8(8):. PubMed ID: 31405216
[TBL] [Abstract][Full Text] [Related]
8. Mechanisms underlying effect of the mycotoxin cytochalasin B on induction of cytotoxicity, modulation of cell cycle, Ca
Chang HT; Chou CT; Chen IS; Yu CC; Lu T; Hsu SS; Shieh P; Jan CR; Liang WZ
Toxicology; 2016 Aug; 370():1-19. PubMed ID: 27640744
[TBL] [Abstract][Full Text] [Related]
9. Visfatin induces stromal cell-derived factor-1 expression by β1 integrin signaling in colorectal cancer cells.
Huang WS; Chen CN; Sze CI; Teng CC
J Cell Physiol; 2013 May; 228(5):1017-24. PubMed ID: 23042611
[TBL] [Abstract][Full Text] [Related]
10. Visfatin: a new player in mesangial cell physiology and diabetic nephropathy.
Song HK; Lee MH; Kim BK; Park YG; Ko GJ; Kang YS; Han JY; Han SY; Han KH; Kim HK; Cha DR
Am J Physiol Renal Physiol; 2008 Nov; 295(5):F1485-94. PubMed ID: 18768589
[TBL] [Abstract][Full Text] [Related]
11. The blockage of survivin and securin expression increases the cytochalasin B-induced cell death and growth inhibition in human cancer cells.
Chao JI; Liu HF
Mol Pharmacol; 2006 Jan; 69(1):154-64. PubMed ID: 16219911
[TBL] [Abstract][Full Text] [Related]
12. Adipokine Visfatin's Role in Pathogenesis of Diabesity and Related Metabolic Derangements.
Kumari B; Yadav UCS
Curr Mol Med; 2018; 18(2):116-125. PubMed ID: 29974830
[TBL] [Abstract][Full Text] [Related]
13. Pre-B cell colony enhancing factor (PBEF)/visfatin induces secretion of MCP-1 in human endothelial cells: role in visfatin-induced angiogenesis.
Adya R; Tan BK; Chen J; Randeva HS
Atherosclerosis; 2009 Jul; 205(1):113-9. PubMed ID: 19166999
[TBL] [Abstract][Full Text] [Related]
14. Nuclear transport of nicotinamide phosphoribosyltransferase is cell cycle-dependent in mammalian cells, and its inhibition slows cell growth.
Svoboda P; Krizova E; Sestakova S; Vapenkova K; Knejzlik Z; Rimpelova S; Rayova D; Volfova N; Krizova I; Rumlova M; Sykora D; Kizek R; Haluzik M; Zidek V; Zidkova J; Skop V
J Biol Chem; 2019 May; 294(22):8676-8689. PubMed ID: 30975903
[TBL] [Abstract][Full Text] [Related]
15. Resistin and Visfatin Expression in HCT-116 Colorectal Cancer Cell Line.
Ghaemmaghami S; Mohaddes SM; Hedayati M; Gorgian Mohammadi M; Dehbashi G
Int J Mol Cell Med; 2013; 2(3):143-50. PubMed ID: 24551805
[TBL] [Abstract][Full Text] [Related]
16. Visfatin and global histone H3K9me levels in colon cancer.
Al Abdulsalam EA; Al Harithy RN
Ann Med; 2021 Dec; 53(1):647-652. PubMed ID: 34008459
[TBL] [Abstract][Full Text] [Related]
17. Visfatin is regulated by rosiglitazone in type 2 diabetes mellitus and influenced by NFκB and JNK in human abdominal subcutaneous adipocytes.
McGee KC; Harte AL; da Silva NF; Al-Daghri N; Creely SJ; Kusminski CM; Tripathi G; Levick PL; Khanolkar M; Evans M; Chittari MV; Patel V; Kumar S; McTernan PG
PLoS One; 2011; 6(6):e20287. PubMed ID: 21694775
[TBL] [Abstract][Full Text] [Related]
18. [The role of visfatin in the pathophysiology of human].
Skoczylas A
Wiad Lek; 2009; 62(3):190-6. PubMed ID: 20229717
[TBL] [Abstract][Full Text] [Related]
19. Elevated serum visfatin levels are associated with poor prognosis of hepatocellular carcinoma.
Sun Y; Zhu S; Wu Z; Huang Y; Liu C; Tang S; Wei L
Oncotarget; 2017 Apr; 8(14):23427-23435. PubMed ID: 28178643
[TBL] [Abstract][Full Text] [Related]
20. Effect of glucagon-like peptide-1 analogue; Exendin-4, on cognitive functions in type 2 diabetes mellitus; possible modulation of brain derived neurotrophic factor and brain Visfatin.
Abdelwahed OM; Tork OM; Gamal El Din MM; Rashed L; Zickri M
Brain Res Bull; 2018 May; 139():67-80. PubMed ID: 29421245
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
